pirozadil has been researched along with Hyperlipidemias in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pedraz de Cabo, J | 1 |
Hirai, Y; Kawakami, M; Koyama, S; Mishima, Y; Mizutani, A; Morishita, S; Saito, T | 1 |
Marti Ragué, I; Tapounet, R | 1 |
3 other study(ies) available for pirozadil and Hyperlipidemias
Article | Year |
---|---|
[Clinical pharmacology of pirozadil].
Topics: Brain Diseases; Coronary Disease; Female; Humans; Hyperlipidemias; Hypertension; Lipids; Male; Pyridines | 1982 |
[Strains and species differences in experimental hyperlipidemia].
Topics: Animals; Clofibrate; Disease Models, Animal; Gemfibrozil; Glycerides; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Niacin; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Species Specificity | 1986 |
The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pyridines; Spain; Triglycerides | 1987 |